Orca Pharmaceuticals, Ltd.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Vertex Gene-Editing Play Inc

"The Pink Sheet" regularly covers noteworthy deal-making in the biopharmaceutical industry. Here is a roundup of key transactions occurring between Sept. 19 and Oct. 2. Genzyme/Alnylam Alnylam Phar

Financings Representing a 72% increase over Q4 2014, first-quarter 2015 financing totaled $15.1 billion and featured 187 transactions (52 more than Q4). ( See Exhibit 1. ) Exhibit 1 Q1 2015 Biopharma

“The Pink Sheet” regularly provides coverage of noteworthy biopharmaceutical business deals. Here is a roundup of the most significant deals that occurred between Feb. 20-26. Bristol/Flexus & Bristol